Reports

Ideas That Generate Results

Global Liquid Biopsy Market Outlook to 2020

Global Liquid Biopsy Market Outlook to 2020

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Feb, 2016| No. of Pages : 90

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1500.00
CD-ROM Mail Delivery
US$ 1600.00
Hard Copy Mail Delivery
US$ 1600.00
Electronic Access - Multi-User License
US$ 2000.00

1. Analyst View

2. Research Methodology

3. Liquid Biopsy - An Introduction

4. Market Dynamics
    4.1 Market Drivers
            4.1.1 High Prevalence of Cancer
            4.1.2 Technological Advancements in Personalized Therapies
            4.1.3 Increasing Demand for Minimally-Invasive Biopsy Techniques
            4.1.4 Lower Cost
            4.1.5 Growing Interest of Venture Capital Firms
    4.2 Market Restraints
           4.2.1 A Less-Defined Regulatory Environment
           4.2.2 Comparatively Low Concentration of Molecular Biomarkers in Body Fluids
           4.2.3 Need for Proper Handling and Storage of the Samples
   4.3 Market Opportunities
          4.3.1 Exosomes Offer Great Advantages as Source Materials
          4.3.2 Next Generation Sequencing Offers Significant Opportunity
          4.3.3 Prenatal Screening & Organ Transplantation: Upcoming Applications
          4.3.4 Growing Researches on Cerebrospinal Fluid as Sample Source
   4.4 Industry Trends
          4.4.1 Strong Preference for ctDNA Among Various Biomarkers
          4.4.2 Blood: The Most Widely Used Sample

5. Global Liquid Biopsy Market Outlook to 2020

6. Global Liquid Biopsy Market Size by Technology
     6.1 Circulating Tumor Cells (CTCs)
     6.2 Circulating Tumor DNA/Cell free DNA (ctDNA/cfDNA)
     6.3 Exosomes

7. Global Liquid Biopsy Market Size by Sample Type
     7.1 Blood
     7.2 Urine

8. Global Liquid Biopsy Market Size by Geography
     8.1 North America
     8.2 Europe
     8.3 Asia
     8.4 Rest of the World (RoW)

9. Pipeline Analysis

10. Key Player Analysis
      10.1 Personal Genome Diagnostics
      10.2 Guardant Health, Inc.
      10.3 Pathway Genomics
      10.4 NeoGenomics, Inc.
      10.5 RainDance Technology
      10.6 Trovagene, Inc.
      10.7 Circulogene Theranostics
      10.8 Biocartis
      10.9 Cynvenio Biosystems, Inc.
      10.10 Biocept, Inc.
      10.11 ANGLE plc
      10.12 MDxHealth
      10.13 Clearbridge BioMedics Pte Ltd
      10.14 Exosome Diagnostics, Inc.

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.